ESCs/iPSCs

A new review article discusses pluripotent stem cell models employed in the understanding and treatment of hearing loss

Research using iPSC-derived organoids support primary cell‐intrinsic and secondary mechanical causes of altered development in the congenital diaphragmatic hernia lung

Selecting cells with high inherent reprogramming potential via CAG promoter activity represents a possible means to improve reprogramming efficiency

Synthetic mRNA‐induced differentiation may accelerate our understanding of Parkinson's disease development in GD1 patients

A new review summarizes advances in iPSC‐based modeling to explore glial cell involvement in neurodegenerative diseases

iPSC-derived AMD model used to investigate the interplay between lysosome function and complement activation in the hope of identifying therapeutic targets

The miR‐183/96/182 cluster controls retinal tissue morphogenesis and represents an important regulator of PAX6 expression

Modulating the miR‐184/Wnt3 pathway in embryonic stem cells may provide for the development of efficient cell therapies for the damaged heart

CDK8/19 Mediator components control pluripotent stem cell differentiation and self-renewal and regulate preimplantation naïve epiblast gene expression

Kanagaki et al. underscore the potential utility of iPSC-derived AT1cells in understanding their differentiation from AT2 cells in vitro.